Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.91 - $5.11 $6,081 - $16,270
-3,184 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.02 - $10.47 $4,332 - $9,035
-863 Reduced 21.32%
3,184 $16,000
Q3 2021

Nov 15, 2021

SELL
$12.2 - $16.75 $78,287 - $107,484
-6,417 Reduced 61.32%
4,047 $53,000
Q2 2021

Aug 16, 2021

BUY
$12.03 - $17.51 $125,881 - $183,224
10,464 New
10,464 $147,000

About Finch Therapeutics Group, Inc.


  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $525M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.